Peter Traxler

Pooled CRISPR screening with single-cell transcriptome readout

Paul Datlinger, André F. Rendeiro, Christian Schmidl et al. · Nature Methods · 2017 · 1.1K citations · Full text

Life Sciences, Biotechnology, Molecular Biology +12

Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma.

Christiane J. Bruns, Carmen C. Solórzano, Matthew T. Harbison et al. · PubMed · 2000 · 501 citations

Medicine, Oncology, Pharmacology +17

Imatinib Mesylate Is a Potent Inhibitor of the ABCG2 (BCRP) Transporter and Reverses Resistance to Topotecan and SN-38 <b> <i>in Vitro</i> </b>

Peter J. Houghton, Glen S. Germain, Franklin C. Harwood et al. · Cancer Research · 2004 · 322 citations · Full text

Medicine, Oncology, Pharmacology +15

AEE788

Peter Traxler, Peter R. Allegrini, Ralf Brandt et al. · Cancer Research · 2004 · 318 citations

Medicine, Oncology, Pharmacology +17

Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition

Ranjit K. Goudar, Qing Shi, Mark D. Hjelmeland et al. · Molecular Cancer Therapeutics · 2005 · 245 citations · Full text

Medicine, Oncology, Pharmacology +17